Please provide your email address to receive an email when new articles are posted on . 10.5% of patients treated with isotretinoin experienced mood changes. 88% of patients experienced symptom ...

-Denifanstat (ASC40) met all primary, key secondary and secondary efficacy endpoints (ITT analysis) and significantly improved moderate-to-severe acne vulgaris compared with placebo in a randomized, ...

Millions of people deal with acne, but those who suffer from cystic acne know how difficult it is to treat compared to ordinary pimples. Cystic acne is a severe form of acne that results in large, pus ...

Select independently determines what we cover and recommend. When you buy through our links, we may earn a commission. Learn more. Millions of people deal with acne, but those who suffer from cystic ...

Oral FASN inhibitors offer a novel mechanism of action for the potential treatment of moderate to severe acne Sagimet initiated first-in-human Phase 1 clinical trial of a second FASN inhibitor, ...

While each product featured is independently selected by our editors, we may include paid promotion. If you buy something through our links, we may earn commission. Read more about our Product Review ...

Branded content. Us Weekly has affiliate partnerships so we may receive compensation for some links to products and services. While acne can be a damaging skin condition that predominates within your ...

Final patient visit marks key milestone for Biofrontera, with top-line results expected Q1 2026 Company plans FDA discussion in Q3 2026 to advance Phase 3 program and potential label expansion More ...

SAN DIEGO, June 10, 2020 /PRNewswire/ -- Dermata Therapeutics' lead clinical candidate, DMT310, produced statistically significant results at week 4, 8 and 12 for all its primary and secondary ...

Cystic acne is the largest and most painful form of acne, causing cysts deep beneath the skin. Cystic acne can be caused by hormones, genetics, and lifestyle factors like diet and stress. To treat ...